πŸ‡ΊπŸ‡Έ FDA
Patent

US 9752144

Inhibitors of MYH7B and uses thereof

granted A61KA61K2300/00A61K31/7105

Quick answer

US patent 9752144 (Inhibitors of MYH7B and uses thereof) held by MIRAGEN THERAPEUTICS, INC. expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MIRAGEN THERAPEUTICS, INC.
Grant date
Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K2300/00, A61K31/7105, A61K31/713, A61K45/06